Macrophages in skin injury and repair

Immunobiology

Volumn 216, Issue 7, 2011, Pages 753-762

  Delavary, Babak Mahdavian ^a   van der Veer, Willem M ^a   van Egmond, Marjolein ^a   Niessen, Frank B ^a   Beelen, Robert H J ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Inflammation; Macrophages; Phenotype; Remodelling; Skin; Wound healing

Indexed keywords

CYTOKINE; PLATELET DERIVED GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN;

ANGIOGENESIS; BLOOD CLOT; BLOOD VESSEL INJURY; CELL FUNCTION; CELL PROLIFERATION; CYTOKINE PRODUCTION; EPITHELIZATION; EXTRACELLULAR MATRIX; HEMOSTASIS; MACROPHAGE; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REGENERATION; REVIEW; SCAR FORMATION; SKIN FIBROBLAST; SKIN INFLAMMATION; SKIN INJURY; WOUND HEALING;

ANIMALS; ANTIGEN PRESENTATION; CELL PROLIFERATION; CICATRIX, HYPERTROPHIC; EXTRACELLULAR MATRIX PROTEINS; HUMANS; INFLAMMATION MEDIATORS; KELOID; MACROPHAGE ACTIVATION; MACROPHAGES; NEOVASCULARIZATION, PATHOLOGIC; SKIN; ULCER; WOUND HEALING;

EID: 79957598147     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2011.01.001     Document Type: Review

References (84)

1. Ashcroft G.S., Yang X., Glick A.B., Weinstein M., Letterio J.L., Mizel D.E., Anzano M., Greenwell-Wild T., Wahl S.M., Deng C., Roberts A.B. Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response. Nat. Cell Biol. 1999, 1:260-266.
2. Baum C.L., Arpey C.J. Normal cutaneous wound healing: clinical correlation with cellular and molecular events. Dermatol. Surg. 2005, 31:674-686.
3. Berse B., Brown L.F., van de W.L., Dvorak H.F., Senger D.R. Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. Mol. Biol. Cell 1992, 3:211-220.
4. Breitkreutz D., Mirancea N., Nischt R. Basement membranes in skin: unique matrix structures with diverse functions?. Histochem. Cell Biol. 2009, 132:1-10.
5. Brown E.J. Phagocytosis. Bioessays 1995, 17:109-117.
6. Bullard K.M., Longaker M.T., Lorenz H.P. Fetal wound healing: current biology. World J. Surg. 2003, 27:54-61.
7. Choi B.M., Kwak H.J., Jun C.D., Park S.D., Kim K.Y., Kim H.R., Chung H.T. Control of scarring in adult wounds using antisense transforming growth factor-beta 1 oligodeoxynucleotides. Immunol. Cell Biol. 1996, 74:144-150.
8. Conejo-Garcia J.R., Buckanovich R.J., Benencia F., Courreges M.C., Rubin S.C., Carroll R.G., Coukos G. Vascular leukocytes contribute to tumor vascularization. Blood 2005, 105:679-681.
9. Daley J.M., Brancato S.K., Thomay A.A., Reichner J.S., Albina J.E. The phenotype of murine wound macrophages. J. Leukoc. Biol. 2010, 87:59-67.
10. Devalaraja R.M., Nanney L.B., Du J., Qian Q., Yu Y., Devalaraja M.N., Richmond A. Delayed wound healing in CXCR2 knockout mice. J. Invest. Dermatol. 2000, 115:234-244.
11. Dipietro L.A., Polverini P.J., Rahbe S.M., Kovacs E.J. Modulation of JE/MCP-1 expression in dermal wound repair. Am. J. Pathol. 1995, 146:868-875.
12. Doherty T.M. T-cell regulation of macrophage function. Curr. Opin. Immunol. 1995, 7:400-404.
13. Dovi J.V., He L.K., Dipietro L.A. Accelerated wound closure in neutrophil-depleted mice. J. Leukoc. Biol. 2003, 73:448-455.
14. Duffield J.S. The inflammatory macrophage: a story of Jekyll and Hyde. Clin. Sci. (Lond.) 2003, 104:27-38.
15. Dvorak H.F., Brown L.F., Detmar M., Dvorak A.M. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am. J. Pathol. 1995, 146:1029-1039.
16. Eming S.A., Krieg T., Davidson J.M. Inflammation in wound repair: molecular and cellular mechanisms. J. Invest. Dermatol. 2007, 127:514-525.
17. Fantin A., Vieira J.M., Gestri G., Denti L., Schwarz Q., Prykhozhij S., Peri F., Wilson S.W., Ruhrberg C. Tissue macrophages act as cellular chaperones for vascular anastomosis downstream of VEGF-mediated endothelial tip cell induction. Blood 2010, 116:829-840.
18. Ferrara N. The role of vascular endothelial growth factor in pathological angiogenesis. Breast Cancer Res. Treat. 1995, 36:127-137.
19. Ferrara N., Heinsohn H., Walder C.E., Bunting S., Thomas G.R. The regulation of blood vessel growth by vascular endothelial growth factor. Ann. N. Y. Acad. Sci. 1995, 752:246-256.
20. Frank S., Hubner G., Breier G., Longaker M.T., Greenhalgh D.G., Werner S. Regulation of vascular endothelial growth factor expression in cultured keratinocytes. Implications for normal and impaired wound healing. J. Biol. Chem. 1995, 270:12607-12613.
21. Frank S., Kampfer H., Wetzler C., Stallmeyer B., Pfeilschifter J. Large induction of the chemotactic cytokine RANTES during cutaneous wound repair: a regulatory role for nitric oxide in keratinocyte-derived RANTES expression. Biochem. J. 2000, 347(Pt 1):265-273.
22. Goerdt S., Orfanos C.E. Other functions, other genes: alternative activation of antigen-presenting cells. Immunity 1999, 10:137-142.
23. Gordon S. Alternative activation of macrophages. Nat. Rev. Immunol. 2003, 3:23-35.
24. Gordon S., Unkeless J.C., Cohn Z.A. Induction of macrophage plasminogen activator by endotoxin stimulation and phagocytosis: evidence for a two-stage process. J. Exp. Med. 1974, 140:995-1010.
25. Gratchev A., Guillot P., Hakiy N., Politz O., Orfanos C.E., Schledzewski K., Goerdt S. Alternatively activated macrophages differentially express fibronectin and its splice variants and the extracellular matrix protein betaIG-H3. Scand. J. Immunol. 2001, 53:386-392.
26. Greenburg G.B., Hunt T.K. The proliferative response in vitro of vascular endothelial and smooth muscle cells exposed to wound fluids and macrophages. J. Cell Physiol. 1978, 97:353-360.
27. Gurtner G.C., Werner S., Barrandon Y., Longaker M.T. Wound repair and regeneration. Nature 2008, 453:314-321.
28. He S., Blomback M., Bark N., Johnsson H., Wallen N.H. The direct thrombin inhibitors (argatroban, bivalirudin and lepirudin) and the indirect Xa-inhibitor (danaparoid) increase fibrin network porosity and thus facilitate fibrinolysis. Thromb. Haemost. 2010, 103:1076-1084.
29. Howdieshell T.R., Riegner C., Gupta V., Callaway D., Grembowicz K., Sathyanarayana, McNeil P.L. Normoxic wound fluid contains high levels of vascular endothelial growth factor. Ann. Surg. 1998, 228:707-715.
30. Huang J.S., Wang Y.H., Ling T.Y., Chuang S.S., Johnson F.E., Huang S.S. Synthetic TGF-beta antagonist accelerates wound healing and reduces scarring. FASEB J. 2002, 16:1269-1270.
31. Hubner G., Brauchle M., Smola H., Madlener M., Fassler R., Werner S. Differential regulation of pro-inflammatory cytokines during wound healing in normal and glucocorticoid-treated mice. Cytokine 1996, 8:548-556.
32. Huet E., Vallee B., Szul D., Verrecchia F., Mourah S., Jester J.V., Hoang-Xuan T., Menashi S., Gabison E.E. Extracellular matrix metalloproteinase inducer/CD147 promotes myofibroblast differentiation by inducing alpha-smooth muscle actin expression and collagen gel contraction: implications in tissue remodeling. FASEB J. 2008, 22:1144-1154.
33. Imhof B.A., Urrand-Lions M. Adhesion mechanisms regulating the migration of monocytes. Nat. Rev. Immunol. 2004, 4:432-444.
34. Ishida Y., Gao J.L., Murphy P.M. Chemokine receptor CX3CR1 mediates skin wound healing by promoting macrophage and fibroblast accumulation and function. J. Immunol. 2008, 180:569-579.
35. Jia T., Pamer E.G. Immunology. Dispensable but not irrelevant. Science 2009, 325:549-550.
36. Jones P.A., Scott-Burden T. Activated macrophages digest the extracellular matrix proteins produced by cultured cells. Biochem. Biophys. Res. Commun. 1979, 86:71-77.
37. Kalluri R., Neilson E.G. Epithelial-mesenchymal transition and its implications for fibrosis. J. Clin. Invest. 2003, 112:1776-1784.
38. Khallou-Laschet J., Varthaman A., Fornasa G., Compain C., Gaston A.T., Clement M., Dussiot M., Levillain O., Graff-Dubois S., Nicoletti A., Caligiuri G. Macrophage plasticity in experimental atherosclerosis. PLoS One 2010, 5:e8852.
39. Knighton D.R., Hunt T.K., Scheuenstuhl H., Halliday B.J., Werb Z., Banda M.J. Oxygen tension regulates the expression of angiogenesis factor by macrophages. Science 1983, 221:1283-1285.
40. Leibovich S.J., Ross R. The role of the macrophage in wound repair. A study with hydrocortisone and antimacrophage serum. Am. J. Pathol. 1975, 78:71-100.
41. Lucas T., Waisman A., Ranjan R., Roes J., Krieg T., Muller W., Roers A., Eming S.A. Differential roles of macrophages in diverse phases of skin repair. J. Immunol. 2010, 184:3964-3977.
42. Macdonald K.P., Palmer J.S., Cronau S., Seppanen E., Olver S., Raffelt N.C., Kuns R., Pettit A.R., Clouston A., Wainwright B., Branstetter D., Smith J., Paxton R.J., Cerretti D.P., Bonham L., Hill G.R., Hume D.A. An antibody against the colony-stimulating factor 1 receptor (CSF1R) depletes the resident subset of monocytes and tissue and tumor-associated macrophages but does not inhibit inflammation. Blood 2010.
43. Madlener M., Parks W.C., Werner S. Matrix metalloproteinases (MMPs) and their physiological inhibitors (TIMPs) are differentially expressed during excisional skin wound repair. Exp. Cell Res. 1998, 242:201-210.
44. Mantovani A., Sozzani S., Locati M., Allavena P., Sica A. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 2002, 23:549-555.
45. Maraganore J.M. Thrombin, thrombin inhibitors, and the arterial thrombotic process. Thromb. Haemost. 1993, 70:208-211.
46. Marin V., Montero-Julian F.A., Gres S., Boulay V., Bongrand P., Farnarier C., Kaplanski G. The IL-6-soluble IL-6Ralpha autocrine loop of endothelial activation as an intermediate between acute and chronic inflammation: an experimental model involving thrombin. J. Immunol. 2001, 167:3435-3442.
47. Martin P., Leibovich S.J. Inflammatory cells during wound repair: the good, the bad and the ugly. Trends Cell Biol. 2005, 15:599-607.
48. Martinez-Ferrer M., Fshar-Sherif A.R., Uwamariya C., de C.B., Davidson J.M., Bhowmick N.A. Dermal transforming growth factor-beta responsiveness mediates wound contraction and epithelial closure. Am. J. Pathol. 2010, 176:98-107.
49. Middleton M., Thatcher N. G- and GM-CSF. Int. J. Antimicrob. Agents 1998, 10:91-93.
50. Midwood K.S., Williams L.V., Schwarzbauer J.E. Tissue repair and the dynamics of the extracellular matrix. Int. J. Biochem. Cell Biol. 2004, 36:1031-1037.
51. Mirza R., Dipietro L.A., Koh T.J. Selective and specific macrophage ablation is detrimental to wound healing in mice. Am. J. Pathol. 2009, 175:2454-2462.
52. Mohle R., Green D., Moore M.A., Nachman R.L., Rafii S. Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:663-668.
53. Mosser D.M. The many faces of macrophage activation. J. Leukoc. Biol. 2003, 73:209-212.
54. Mosser D.M., Edwards J.P. Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 2008, 8:958-969.
55. Niessen F.B., Andriessen M.P., Schalkwijk J., Visser L., Timens W. Keratinocyte-derived growth factors play a role in the formation of hypertrophic scars. J. Pathol. 2001, 194:207-216.
56. Niessen F.B., Spauwen P.H., Schalkwijk J., Kon M. On the nature of hypertrophic scars and keloids: a review. Plast. Reconstr. Surg. 1999, 104:1435-1458.
57. O'Kane S., Ferguson M.W. Transforming growth factor beta s and wound healing. Int. J. Biochem. Cell Biol. 1997, 29:63-78.
58. Pascual D.W., Bost K.L. Substance P production by P388D1 macrophages: a possible autocrine function for this neuropeptide. Immunology 1990, 71:52-56.
59. Porcheray F., Viaud S., Rimaniol A.C., Leone C., Samah B., reuddre-Bosquet N., Dormont D., Gras G. Macrophage activation switching: an asset for the resolution of inflammation. Clin. Exp. Immunol. 2005, 142:481-489.
60. Ravanti L., Kahari V.M. Matrix metalloproteinases in wound repair (review). Int. J. Mol. Med. 2000, 6:391-407.
61. Roberts A.B., Russo A., Felici A., Flanders K.C. Smad3: a key player in pathogenetic mechanisms dependent on TGF-beta. Ann. N. Y. Acad. Sci. 2003, 995:1-10.
62. Ross R., Everett N.B., Tyler R. Wound healing and collagen formation. VI. The origin of the wound fibroblast studied in parabiosis. J. Cell Biol. 1970, 44:645-654.
63. Santoro M.M., Gaudino G. Cellular and molecular facets of keratinocyte reepithelization during wound healing. Exp. Cell Res. 2005, 304:274-286.
64. Schmidt T., Carmeliet P. Blood-vessel formation: bridges that guide and unite. Nature 2010, 465:697-699.
65. Shah M., Foreman D.M., Ferguson M.W. Neutralisation of TGF-beta 1 and TGF-beta 2 or exogenous addition of TGF-beta 3 to cutaneous rat wounds reduces scarring. J. Cell Sci. 1995, 108(Pt. 3):985-1002.
66. Shapiro S.D., Kobayashi D.K., Ley T.J. Cloning and characterization of a unique elastolytic metalloproteinase produced by human alveolar macrophages. J. Biol. Chem. 1993, 268:23824-23829.
67. Shweiki D., Itin A., Soffer D., Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 1992, 359:843-845.
68. Simpson D.M., Ross R. The neutrophilic leukocyte in wound repair a study with antineutrophil serum. J. Clin. Invest. 1972, 51:2009-2023.
69. Singer A.J., Clark R.A. Cutaneous wound healing. N. Engl. J. Med. 1999, 341:738-746.
70. Stavri G.T., Zachary I.C., Baskerville P.A., Martin J.F., Erusalimsky J.D. Basic fibroblast growth factor upregulates the expression of vascular endothelial growth factor in vascular smooth muscle cells. Synergistic interaction with hypoxia. Circulation 1995, 92:11-14.
71. Stout R.D. Editorial: macrophage functional phenotypes: no alternatives in dermal wound healing?. J. Leukoc. Biol. 2010, 87:19-21.
72. Stout R.D., Watkins S.K., Suttles J. Functional plasticity of macrophages: in situ reprogramming of tumor-associated macrophages. J. Leukoc. Biol. 2009, 86:1105-1109.
73. Swirski F.K., Nahrendorf M., Etzrodt M., Wildgruber M., Cortez-Retamozo V., Panizzi P., Figueiredo J.L., Kohler R.H., Chudnovskiy A., Waterman P., Aikawa E., Mempel T.R., Libby P., Weissleder R., Pittet M.J. Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science 2009, 325:612-616.
74. Tammela T., Zarkada G., Wallgard E., Murtomaki A., Suchting S., Wirzenius M., Waltari M., Hellstrom M., Schomber T., Peltonen R., Freitas C., Duarte A., Isoniemi H., Laakkonen P., Christofori G., Yla-Herttuala S., Shibuya M., Pytowski B., Eichmann A., Betsholtz C., Alitalo K. Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation. Nature 2008, 454:656-660.
75. Thakral K.K., Goodson W.H., Hunt T.K. Stimulation of wound blood vessel growth by wound macrophages. J. Surg. Res. 1979, 26:430-436.
76. Tredget E.E., Yang L., Delehanty M., Shankowsky H., Scott P.G. Polarized Th2 cytokine production in patients with hypertrophic scar following thermal injury. J. Interferon Cytokine Res. 2006, 26:179-189.
77. van der Veer, Bloemen M.C., Ulrich M.M., Molema G., van Zuijlen P.P., Middelkoop E., Niessen F.B. Potential cellular and molecular causes of hypertrophic scar formation. Burns 2009, 35:15-29.
78. van Hinsbergh V.W., Koolwijk P., Hanemaaijer R. Role of fibrin and plasminogen activators in repair-associated angiogenesis: in vitro studies with human endothelial cells. EXS 1997, 79:391-411.
79. Vogler R., Sauer B., Kim D.S., Schafer-Korting M., Kleuser B. Sphingosine-1-phosphate and its potentially paradoxical effects on critical parameters of cutaneous wound healing. J. Invest. Dermatol. 2003, 120:693-700.
80. Wang R., Ghahary A., Shen Q., Scott P.G., Roy K., Tredget E.E. Hypertrophic scar tissues and fibroblasts produce more transforming growth factor-beta1 mRNA and protein than normal skin and cells. Wound. Repair Regen. 2000, 8:128-137.
81. Weitkamp B., Cullen P., Plenz G., Robenek H., Rauterberg J. Human macrophages synthesize type VIII collagen in vitro and in the atherosclerotic plaque. FASEB J. 1999, 13:1445-1457.
82. Werner S., Grose R. Regulation of wound healing by growth factors and cytokines. Physiol. Rev. 2003, 83:835-870.
83. Wilson H.M., Chettibi S., Jobin C., Walbaum D., Rees A.J., Kluth D.C. Inhibition of macrophage nuclear factor-kappaB leads to a dominant anti-inflammatory phenotype that attenuates glomerular inflammation in vivo. Am. J. Pathol. 2005, 167:27-37.
84. Wynn T.A. Cellular and molecular mechanisms of fibrosis. J. Pathol. 2008, 214:199-210.